Literature DB >> 2612585

Selective presence of acid hydrolases in the interphotoreceptor matrix.

A J Adler1.   

Abstract

Adler and Martin (1983, Curr. Eye Res. 2, 359-66) found cathepsin D to be present in crude preparations of bovine interphotoreceptor matrix (IPM). The purpose of the present study was to determine, by investigating several acid hydrolases in purer IPM samples, whether hydrolytic enzymes abundant in RPE lysosomes were present also as normal components of the IPM. IPM was prepared from bovine eyes by the introduction of a small bleb of buffer between the neural retina and the RPE. These IPM samples were free from significant contamination by surrounding tissues; they contained IRBP as their only major protein, and had negligible amounts of lactate dehydrogenase and ROS-specific proteins. Most acid hydrolases were assayed fluorometrically by measuring the 4-methylumbelliferone released upon hydrolysis of appropriate derivatives; the substrate for cathepsin was hemoglobin. The amounts of the enzymes found in the IPM were far from uniform and could not be correlated with enzyme activities in either RPE or retina homogenates. The hydrolases in the IPM varied in amount from beta-galactosidase (28% of the RPE level), through N-acetyl-beta-glucosaminidase (20%), alpha-fucosidase (15%), beta-glucuronidase (12%), alpha-glucosidase (8%), cathepsin D (7%), alpha-mannosidase (7%), down to beta-glucosidase, acid phosphatase, and acid lipase (trace amounts, less than 1%). These results agree with the relative amounts of enzymes found by Wilcox (1987) to be secreted into the medium by cultured human RPE cells. Furthermore, the rank order of hydrolases in the IPM is the same as that for hydrolases secreted (but not recaptured) by human fibroblasts in I-cell disease. The conclusion from these correlations is that lysosomal enzymes are probably secreted, as a normal process, by the RPE into the IPM, where they may have a role in digesting shed outer segments and in catabolizing IPM components.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2612585     DOI: 10.1016/s0014-4835(89)80027-2

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  8 in total

1.  Comparative pathology of murine mucolipidosis types II and IIIC.

Authors:  P Vogel; B J Payne; R Read; W-S Lee; C M Gelfman; S Kornfeld
Journal:  Vet Pathol       Date:  2009-03       Impact factor: 2.221

2.  Assays for the antiangiogenic and neurotrophic serpin pigment epithelium-derived factor.

Authors:  Preeti Subramanian; Susan E Crawford; S Patricia Becerra
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

3.  Solubility, stability, physicochemical characteristics and in vitro ocular tissue permeability of hesperidin: a natural bioflavonoid.

Authors:  Soumyajit Majumdar; Ramesh Srirangam
Journal:  Pharm Res       Date:  2008-09-23       Impact factor: 4.200

4.  αB crystallin is apically secreted within exosomes by polarized human retinal pigment epithelium and provides neuroprotection to adjacent cells.

Authors:  Parameswaran G Sreekumar; Ram Kannan; Mizuki Kitamura; Christine Spee; Ernesto Barron; Stephen J Ryan; David R Hinton
Journal:  PLoS One       Date:  2010-10-08       Impact factor: 3.240

5.  Retinal pigment epithelial acid lipase activity and lipoprotein receptors: effects of dietary omega-3 fatty acids.

Authors:  Victor M Elner
Journal:  Trans Am Ophthalmol Soc       Date:  2002

6.  Release of lysosomal protease from retinal pigment epithelium and fibroblasts during mechanical stresses.

Authors:  H L Kain; U Reuter
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-04       Impact factor: 3.117

7.  Knock-down of cathepsin D affects the retinal pigment epithelium, impairs swim-bladder ontogenesis and causes premature death in zebrafish.

Authors:  Carlo Follo; Matteo Ozzano; Vera Mugoni; Roberta Castino; Massimo Santoro; Ciro Isidoro
Journal:  PLoS One       Date:  2011-07-01       Impact factor: 3.240

8.  Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease.

Authors:  Rebecca E H Whiting; Cheryl A Jensen; Jacqueline W Pearce; Lauren E Gillespie; Daniel E Bristow; Martin L Katz
Journal:  Exp Eye Res       Date:  2016-04-01       Impact factor: 3.467

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.